Despite extensive research on the topic, there is currently a dearth of data on the impact of genetic mutations associated with adult-onset FSGS, including but not limited to INF2, ACTN4, TRPC6, and PAX2, on the risk of disease recurrence post-transplantation. This evidence concerns the gene TRPC6 and focal segmental glomerulosclerosis.